The development program
"«Marbopharm» Development plan” progect on manufacturing finished drugs» is planned to be realized. The financial sources of the progect are incomes, depreciation charges, loan.
The development strategy includes:
The expansion of the product range: more than 30 new preparations are being develoed and registrated now;
A phased reconstruction of pre-2020 manufacturing;
Introduction of new modern technologies;
Transition to international pharmaceutical standards.
The events of the plan are orientated on the significant expansion of solid and liquid pharmaceutical preparations production, the ensure of the licensing requirements, the transition to the development of new drugs on the current level and reducing energy costs.
The reconstruction of the substance manufacture is orientated on bringing the sites into compliance with the requirements of the GMP.